Company · founded 1998
Emergent BioSolutions (United States)
Gaithersburg, United States · emergentbiosolutions.com
- Citations, last 5 years
- 593
- Works, last 5 years
- 61
- h-index
- 64
- Scientists listed
- 13
- Grants since 2016
- 8
Grants received
2024–2025 · research · R43
E. coli platform for expression of low-cost malaria fusion proteins
Andrew Lees · Emergent BioSolutions (United States) · funded by National Institutes of Health
2020–2021 · research · R43
Genetically detoxified tetanus toxin for use in vaccines
Andrew Lees · Emergent BioSolutions (United States) · funded by National Institutes of Health
2019–2022 · cooperative agreement · UG3
Nalmefene Long-Acting Injectable (AP007) for the Treatment of Opioid Use Disorder
Andrew Walker · Emergent BioSolutions (United States) · funded by National Institutes of Health
2014–2023 · contract · N01
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
Laurence Lemiale · Emergent BioSolutions (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
Laurence Lemiale · Emergent BioSolutions (United States) · funded by National Institutes of Health
2014–2024 · contract · N01
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
Laurence Lemiale · Emergent BioSolutions (United States) · funded by National Institutes of Health
2014–2020 · contract · N01
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
Laurence Lemiale · Emergent BioSolutions (United States) · funded by National Institutes of Health
2008–2021 · contract · N01
Development of an Anthrax Vaccine
Sukjoon Park · Emergent BioSolutions (United States) · funded by National Institutes of Health